Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging
Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of DetectionSOUTH SAN FRANCISCO, Calif., April 11, 2022 (GLOBE...
Month: April 2022
Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 OraGrowtH210 Trial Evaluating Oral LUM-201 in PGHD
- Interim Data Anticipated by End of 2022 - - Interim Data from PK/PD OraGrowtH212 Trial also Anticipated by End...
Nuvectis Pharma Recaps Oral Presentation Highlights for NXP800 at the 2022 American Association for Cancer Research (AACR) Conference
Fort Lee, NJ, April 11, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis” or the “Company”), a biopharmaceutical...
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech”...
SELLAS Life Sciences’ Newly Licensed GFH009 Asset Shows Significant Anti-Leukemic Effect in Acute Myeloid Leukemia Patients Relapsed/Refractory to Venetoclax in Ongoing Phase 1 Study
- Fifth Dose Level Cohort of GFH009, a Highly Selective CDK9 Inhibitor, Initiated - - No Dose-Limiting Toxicities in First...
Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom Farms Division Expands in North America
Purchase of 100 acres farmland for $1.85 Million, in Ontario, Canada to close in June 2022Through experienced partners, Red Light's...
Halberd Entering the Medical Metaverse
Jackson Center, Pennsylvania--(Newsfile Corp. - April 11, 2022) - Halberd Corporation (OTC PINK: HALB) announces plans to enter the Metaverse...
Research: Chronic Data Readiness Issues Impeding Digital Transformation in Healthcare
New research finds healthcare leaders have high aspirations for digital transformation, but a lack of data readiness threatens their ability...
Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the...
TRUVIC Announces 510(k) Clearance for the Prodigy™ Thrombectomy System
First regulatory milestone as part of a strategy to advance patient care CAMPBELL, Calif.--(BUSINESS WIRE)--Truvic Medical, Inc., a wholly owned...
Equideum Health and Nokia Bell Labs Collaborate to Empower Individuals to Own and Benefit from Health Data Sourced from Edge Devices
Equideum Health and Nokia Bell Labs are collaborating with a focus on integrating and leveraging edge datasets to be made...
Chairman W. Stancil Starnes to Retire From ProAssurance Board of Directors
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) today announced that W. Stancil (Stan) Starnes, Executive Chairman of the Board of Directors, will...
Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf (UKE) Opens New Avenues for Personalized Medicine in COVID-19
A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.The...
Notice to Annual General Meeting of Spago Nanomedical AB (publ)
LUND, SWEDEN / ACCESSWIRE / April 11, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)The shareholders of Spago Nanomedical AB (publ), corporate registration...
AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member
PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a...
Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting
- Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and duration of response compared to...
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with...
Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
- SL-9258 (TIGIT-Fc-LIGHT) combined with anti-PD(L)1 broadened anti-tumor activity of the checkpoint antibodies in aggressive CPI-resistant tumors - - Butyrophilin...
Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of...
Cellectis Presents Preclinical Data from its First Allogeneic Dual CAR T-cell Product Candidate UCART20x22 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Preclinical data demonstrated POC with robust in vitro and in vivo anti-tumor activityUCART20x22 allogeneic dual CAR T has been designed...